Miyazaki Kanetaka | Department Of Urology Yokohama Rosai Hospital
スポンサーリンク
概要
関連著者
-
Yamaguchi Kunio
Department Of Urology Yokohama Rosai Hospital
-
Matsumoto Akihiro
Department Of Cardiothoracic Surgery The University Of Tokyo
-
Miyazaki Kanetaka
Department Of Urology Yokohama Rosai Hospital
-
Nozumi Kazuyoshi
Department Of Urology Yokohama Rosai Hospital
-
Inoue Atsushi
Deparmtnent Of Surgery Kuniyoshi Hospital
-
NAGATA MAKI
Department of Environmental Sciences, Faculty of Agriculture, Saga University
-
MATSUMOTO AKIHIRO
Department of Urology, Graduate School of Medicine, Chiba University, and Chiba University Hospital
-
YAMAGUCHI Kunio
Department of Urology, Yokohama Rosai Hospital
-
Kito Hiroki
Department Of Basic Pathology Graduate School Of Medicine Chiba University
-
Nagata Maki
Department Of Urology Yokohama Rosai Hospital
-
INOUE Atsushi
Department of Urology, Yokohama Rosai Hospital
-
YOKOI Satoshi
Department of Urology, Yokohama Rosai Hospital
-
NOZUMI Kazuyoshi
Department of Urology, Yokohama Rosai Hospital
-
MIYAZAKI Kanetaka
Department of Urology, Yokohama Rosai Hospital
-
HOSOKI Shigeru
Department of Urology, Yokohama Rosai Hospital
-
Kakuta Yukio
Department Of Pathology Yokohama Rosai Hospital
-
Goto Yusuke
Department Of Electrical And Electronic Engineering Akita University
-
Suzuki Hiroyoshi
Department Of Electronic Engineering Faculty Of Technology Tokyo University Of Agriculture And Techn
-
Yokoi Satoshi
Department Of Urology Yokohama Rosai Hospital
-
Hosoki Shigeru
Department Of Urology Yokohama Rosai Hospital
-
Matsumoto Akihiro
Department Of Urology Yokohama Rosai Hospital
-
Inoue Atsushi
Department Of Applied Mathematics Fukuoka University
-
Inoue Atsushi
Department Of Urology Yokohama Rosai Hospital
-
Hasegawa Naoki
Department of Applied Physics, Nagoya University, Nagoya 464-8603, Japan
-
KITO Hiroki
Department of Urology, Yokohama Rosai Hospital
-
GOTO Yusuke
Department of Urology, Yokohama Rosai Hospital
著作論文
- Evaluation of docetaxel plus estramustine in the treatment of patients with hormone-refractory prostate cancer
- Active surveillance criteria for prostate cancer : Can they be applied to Japanese patients?